Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Low-dose Buprenorphine Initiation is a Safe and Effective Alternative to Standard-dose Buprenorphine in Hospitalized Patients with OUD

Nhan Vuong, MD

Dr. Vuong

Clinical question: Is low-dose buprenorphine initiation in hospitalized patients safe and effective for the management of opioid use disorder (OUD)?

Background: OUD is a chronic relapsing disease that has become an epidemic in the U.S. Medications for opioid use disorder (MOUD) have been shown to be effective in preventing overdose-related deaths. Buprenorphine has a good safety profile and accessibility. However, standard dose initiation has been limited by requiring complete cessation of opioids or a withdrawal period prior to initiation, which may not be feasible in the inpatient setting.

Study design: Retrospective cohort study

Setting: Urban, academic medical center

Synopsis: 68 patients seen by an addiction-medicine consult service were initiated on low-dose buprenorphine. Low-dose buprenorphine was chosen over standard dosing for the following reasons: co-occurring pain (91.7%), anxiety surrounding withdrawal (69.4%), history of precipitated withdrawal (9.7%), opioid withdrawal intolerance (6.9%), and other (18.1%). Of these, 50 patients (69.4%) completed initiation as an inpatient, nine patients (12.5%) transitioned to complete initiation as an outpatient, and 13 patients (18.1%) did not complete initiation. Patients experienced mild generalized symptoms, but the study was unable to conclude if they were related to low-dose buprenorphine or acute illness.

The authors describe specific practice considerations for low-dose buprenorphine initiation in the above scenarios. They found that low-dose initiation removed the barrier of a withdrawal period, provided more flexibility for buprenorphine initiation, did not result in increased pain, required less intensive nursing staff monitoring, supported methadone transitions, and allowed for rapid titration protocols.

Study limitations include limited patient diversity, performance at a single site, lack of follow-up after hospitalization, and applicability to other health care systems without an addiction-medicine consult service.

Bottom line: Low-dose buprenorphine is a safe and effective alternative to standard-dose buprenorphine initiation for hospitalized patients with OUD. Hospitalists have increasing options for OUD treatment and with shared decision making can safely initiate therapy in the inpatient setting.

Citation: Button D, et al. Low-dose buprenorphine initiation in hospitalized adults with opioid use disorder: a retrospective cohort analysis. J Addict Med. 2022;16(2):e105-e111. doi:10.1097/ADM.0000000000000864.

Dr. Nhan Vuong is an assistant clinical professor of medicine in the division of hospital medicine at the University of California, San Diego.

  • Low-dose Buprenorphine Initiation is a Safe and Effective Alternative to Standard-dose Buprenorphine in Hospitalized Patients with OUD

    May 1, 2023

  • Becoming a Well-being Advocate

    May 1, 2023

  • Lessons in Redeployment from Adult Hospitalists

    May 1, 2023

  • Reducing Mental Health Care Barriers for Hospitalists

    May 1, 2023

  • SIG Spotlight: Global Hospital Medicine

    May 1, 2023

  • Chapter Spotlight: North Florida

    May 1, 2023

  • Movers and Shakers April 2023

    April 27, 2023

  • Hospital Ephemera

    April 18, 2023

  • Year 2033

    April 18, 2023

  • Slow Down!

    April 18, 2023

1 … 50 51 52 53 54 … 962
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences